13D/13G Filings - Empery Asset Management, LP

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1, ...3, 4, 5, 6, 7, Next
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2021-01-20
11:08 am
Purchase
2020-12-31 13G enVVeno Medical Corporation
HJLI
Empery Asset Management, LP 185,868
4.990%
185,868increase
(New Position)
Filing
History
2021-01-20
11:05 am
Purchase
2020-12-31 13G Genius Brands International, Inc.
GNUS
Empery Asset Management, LP 1,000,000
3.750%
67,143increase
(+7.20%)
Filing
History
2021-01-20
11:03 am
Purchase
2020-12-31 13G Globus Maritime Limited
GLBS
Empery Asset Management, LP 372,494
4.990%
372,494increase
(New Position)
Filing
History
2021-01-20
11:01 am
Sale
2020-12-31 13G Second Sight Medical Products, Inc.
EYES
Empery Asset Management, LP 0
0.000%
-733,333decrease
(Position Closed)
Filing
History
2021-01-19
09:58 am
Purchase
2021-01-14 13G Viveve Medical, Inc.
VIVE
Empery Asset Management, LP 1,029,411
9.960%
1,029,411increase
(New Position)
Filing
History
2021-01-14
09:02 am
Purchase
2021-01-10 13G Applied DNA Sciences, Inc.
APDN
Empery Asset Management, LP 480
6.420%
473increase
(+6880.80%)
Filing
History
2021-01-14
09:00 am
Purchase
2021-01-08 13G Zevra Therapeutics, Inc.
ZVRA
Empery Asset Management, LP 1,230,000
9.990%
1,230,000increase
(New Position)
Filing
History
2021-01-14
09:00 am
Purchase
2021-01-06 13G Atossa Therapeutics, Inc.
ATOS
Empery Asset Management, LP 4,760,500
5.320%
4,760,500increase
(New Position)
Filing
History
2021-01-13
09:03 am
Purchase
2020-12-31 13G Castor Maritime Inc.
CTRM
Empery Asset Management, LP 277,333
9.910%
130,000increase
(+88.24%)
Filing
History
2021-01-13
09:03 am
Sale
2020-12-31 13G CELLECT BIOTECHNOLOGY LTD SPON
APOP
Empery Asset Management, LP 185,200
0.050%
-32,114,800decrease
(-99.43%)
Filing
History
2021-01-13
09:02 am
Sale
2020-12-31 13G Allena Pharmaceuticals, Inc.
ALNAQ
Empery Asset Management, LP 0
0.000%
-2,792,683decrease
(Position Closed)
Filing
History
2021-01-13
09:02 am
Unchanged
2020-12-31 13G Artelo Biosciences, Inc.
ARTL
Empery Asset Management, LP 61,333
4.990%
0
(Unchanged)
Filing
History
2021-01-13
09:01 am
Sale
2020-12-31 13G Baudax Bio, Inc.
BXRX
Empery Asset Management, LP 714
2.600%
-1,374decrease
(-65.79%)
Filing
History
2021-01-13
09:01 am
Purchase
2020-12-31 13G Nuwellis, Inc.
NUWE
Empery Asset Management, LP 137
4.990%
137increase
(New Position)
Filing
History
2021-01-13
09:00 am
Sale
2020-12-31 13G Aethlon Medical, Inc.
AEMD
Empery Asset Management, LP 82,502
4.990%
-21,587decrease
(-20.74%)
Filing
History
2021-01-07
12:47 pm
Purchase
2020-12-31 13G Orbital Infrastructure Group, Inc.
OIG
Empery Asset Management, LP 46,296
5.110%
46,296increase
(New Position)
Filing
History
2020-12-08
09:40 am
Purchase
2020-12-02 13G Envirotech Vehicles, Inc.
ADOM
Empery Asset Management, LP 6,250,005
6.180%
6,250,005increase
(New Position)
Filing
History
2020-12-02
11:12 am
Purchase
2020-11-25 13G Hepion Pharmaceuticals, Inc.
HEPA
Empery Asset Management, LP 2,000
6.910%
2,000increase
(New Position)
Filing
History
2020-11-18
10:08 am
Purchase
2020-11-12 13G InMed Pharmaceuticals Inc.
INM
Empery Asset Management, LP 44
6.350%
44increase
(New Position)
Filing
History
2020-11-12
10:38 am
Purchase
2020-11-05 13G Opus Genetics, Inc.
IRD
Empery Asset Management, LP 591,016
8.330%
591,016increase
(New Position)
Filing
History
Goto Prev, 0, 1, ...3, 4, 5, 6, 7, Next